OLUX Drug Patent Profile
✉ Email this page to a colleague
When do Olux patents expire, and what generic alternatives are available?
Olux is a drug marketed by Norvium Bioscience and is included in two NDAs. There are two patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in OLUX is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Olux
A generic version of OLUX was approved as clobetasol propionate by COSETTE on February 16th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OLUX?
- What are the global sales for OLUX?
- What is Average Wholesale Price for OLUX?
Summary for OLUX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Patent Applications: | 4,476 |
| Drug Prices: | Drug price information for OLUX |
| What excipients (inactive ingredients) are in OLUX? | OLUX excipients list |
| DailyMed Link: | OLUX at DailyMed |
Paragraph IV (Patent) Challenges for OLUX
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| OLUX | Topical Foam | clobetasol propionate | 0.05% | 021142 | 1 | 2005-06-27 |
US Patents and Regulatory Information for OLUX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norvium Bioscience | OLUX | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 021142-001 | May 26, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Norvium Bioscience | OLUX E | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 022013-001 | Jan 12, 2007 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Norvium Bioscience | OLUX E | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 022013-001 | Jan 12, 2007 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OLUX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Norvium Bioscience | OLUX | clobetasol propionate | AEROSOL, FOAM;TOPICAL | 021142-001 | May 26, 2000 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OLUX
See the table below for patents covering OLUX around the world.
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
